Senores Pharmaceuticals IPO Day 1: GMP jumps 38%, Subscription status, Allotment details, and key points to know before investing

Senores Pharmaceuticals, an emerging player in the pharma industry, has kicked off its IPO today (December 20). The bidding window of the public issue is set to close on December 24. The IPO of Senores Pharmaceuticals offers shares in a price range of Rs 372 to Rs 391 per share.

Senores Pharmaceuticals IPO – GMP

As of today and the recent trend, the grey market premium (GMP) for the Senores Pharmaceuticals IPO is Rs 150, indicating that the stock is expected to list at a premium, with an estimated listing price of Rs 541 per share, a 38.36 per cent higher than the upper end of the price band.

Early Subscription Trends

Coming to the IPO’s subscription status, as of the first day and the latest development, the issue so far has been subscribed 44 per cent. The retail investors’ segment lead the charge, with a 1.94 times subscription rate.

Senores Pharmaceuticals – What’s on Offer?

Senores Pharmaceuticals IPO  is a mix of fresh shares worth Rs 500 crore and an Offer for Sale (OFS) of Rs 82.11 crore from existing promoters and shareholders.

Also Read: International Gemological Institute (IGI) Share Price, IPO Listing Live Updates: Check listing, date, time, GMP, and other details

The Senores Pharmaceuticals IPO has a total share offering of 85,34,681 shares. The allocations of the shares across various investor categories are as follows:  

Qualified Institutional Buyers (QIBs)  have been allocated 75 per cent and in the  Non-Institutional Investors (NIIs) category, 15 per cent of the offering is for high-net-worth individuals and other non-institutional investors. The remaining 10 per cent is reserved for retail investors, who can bid for a minimum of 38 shares.

Senores Pharmaceuticals IPO also includes an employee segment, which has been subscribed 65 per cent.

Anchor investors

Senores Pharmaceuticals IPO has raised Rs 261 crore from anchor investors ahead of its opening. Key institutional investors such as ICICI Prudential Mutual Fund, Mahindra Manulife Mutual Fund, Aditya Birla Sun Life Insurance, SBI General Insurance, and Troo Capital.

Also Read: Zomato shares in focus after Sensex Entry: Market cap surpasses Tata Motors and Bajaj Auto

The anchor investors have been allotted 66.66 lakh shares, with each share priced at Rs 391.

 » Read More

Related Articles

2025 could set new records in luxury realty

Luxury sells. And, the capital leads in lapping it up. With this month’s landmark deal of a flat in Gurugram’s DLF Camellias for Rs 190 crore, luxury real estate in Delhi-NCR is on a new high. Among the top seven cities in India, Delhi-NCR stood out with a remarkable 64% share of luxury residential launches

GST Council defers decision on tax rates for health, life insurance premiums – What we know so far

The GST Council on December 21 again deferred a decision to exempt and cut taxes on health and life insurance premiums. The reason for this is that the ministers’ panel needs more time to reach a consensus on the matter. “Some members said more discussions required. We (GoM) will meet in January again,” Bihar Deputy

Hamdard: True Companion of Those in Pain

By Farooq Wani A commitment to giving back to society with a charitable and compassionate spirit has been at the core of the business model adopted and followed by the Delhi-based Hamdard Laboratories India during its 118 years of existence.  Hamdard originates from two Persian words – “Hum”, meaning “companion”, and “Dard” meaning “pain” –

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

2025 could set new records in luxury realty

Luxury sells. And, the capital leads in lapping it up. With this month’s landmark deal of a flat in Gurugram’s DLF Camellias for Rs 190 crore, luxury real estate in Delhi-NCR is on a new high. Among the top seven cities in India, Delhi-NCR stood out with a remarkable 64% share of luxury residential launches

GST Council defers decision on tax rates for health, life insurance premiums – What we know so far

The GST Council on December 21 again deferred a decision to exempt and cut taxes on health and life insurance premiums. The reason for this is that the ministers’ panel needs more time to reach a consensus on the matter. “Some members said more discussions required. We (GoM) will meet in January again,” Bihar Deputy

Hamdard: True Companion of Those in Pain

By Farooq Wani A commitment to giving back to society with a charitable and compassionate spirit has been at the core of the business model adopted and followed by the Delhi-based Hamdard Laboratories India during its 118 years of existence.  Hamdard originates from two Persian words – “Hum”, meaning “companion”, and “Dard” meaning “pain” –

8th Pay Commission Delay: Employees’ Federation plans nationwide agitation in new year – Details inside

8th Pay Commission: With the Centre ruling out any proposal to set up the 8th Central Pay Commission anytime soon, over 1 crore central government employees and pensioners have expressed their displeasure over the delay in announcing the next pay commission, which, according to them, should start its term from January 1, 2026. Amid this

Signature Global emerges as top developer along Dwarka Expressway post-pandemic: Square Yards

Signature Global has emerged as the market leader in the Dwarka Expressway region, as per a recent report by Square Yards which pegs the total annual residential new supply along Dwarka Expressway at 10,000 units per annum since 2020, compared to 5,000–7,000 new units launched per annum in the pre-pandemic period. According to Square Yards